Transdermal Drug Delivery System of Propranolol
Author Information
Author(s): Omray L. K., Kohli S., Khopade A. J., Patil S., Gajbhiye Asmita, Agrawal G. P.
Primary Institution: Guru Ramdas Khalsa Institute of Science and Technology (Pharmacy), Barela, Jabalpur-483 001, India
Hypothesis
The study aimed to develop a mesophasic microreservoir-based transdermal drug delivery system for propranolol.
Conclusion
The mesophasic microreservoir-based transdermal systems are stable, easy to prepare, and can effectively deliver propranolol for treating hypertension.
Supporting Evidence
- The liquid crystalline phase is thermodynamically stable and can be stored unchanged for long periods.
- Controlled release of propranolol was observed over 24 hours from the developed systems.
- Entrapment efficiency of the liquid crystals was found to be 94±2.5%.
Takeaway
This study created a new way to deliver a medicine called propranolol through the skin, which can help people with high blood pressure.
Methodology
The study involved preparing liquid crystals and a transdermal patch, followed by evaluating their properties such as drug release and stability.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website